insights_auto
Why is 9926 down 2.89%?
Dive Deeperchevron_right
9926:HKG
Akeso Inc
HK$104.10
arrow_downward
-2.89%(-3.10) 1D
Oct 13, 11:59:50 AM GMT+8 · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 9926...
Open
HK$105.60
High
HK$106.00
Low
HK$102.20
Mkt. cap
95.89B
Avg. vol.
10.95M
Volume
4.56M
52-wk high
HK$156.00
52-wk low
HK$80.20
EPS
-HK$1.24
No. of employees
4K
Open
HK$105.60
High
HK$106.00
Low
HK$102.20
Mkt. cap
95.89B
Avg. vol.
10.95M
Volume
4.56M
52-wk high
HK$156.00
52-wk low
HK$80.20
EPS
-HK$1.24
No. of employees
4K
News stories
From web sources and news partners
Simply Wall Street
·
2 days ago
Is Akeso (SEHK:9926) Cheap As Its Phase III Colon Cancer Trial Expands Its Pipeline?
Profile
Akeso, Inc is a publicly listed Chinese biopharmaceutical company that is headquartered in Zhongshan, Guangdong.
It is best known for developing Ivonescimab, a cancer treatment antibody. Wikipedia
About Akeso Inc
CEOMichelle Xia | Michelle Xia
Employees4.08K
FoundedMar 19, 2012
Headquarters-
SectorBiotechnology
Websiteakesobio.com